Skip to main content
Adam Binder, MD, Oncology, Philadelphia, PA

Adam Finn Binder MD

Hematologic Oncology


Assistant Professor; Sidney Kimmel Cancer Center; Thomas Jefferson University

Join to View Full Profile
  • 925 Chestnut StSte 320APhiladelphia, PA 19107

  • Phone+1 215-955-8874

  • Fax+1 215-955-2340

Dr. Binder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2010 - 2013
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2010

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2018 - 2026
  • DE State Medical License
    DE State Medical License 2019 - 2025
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • NY State Medical License
    NY State Medical License 2013 - 2025
  • MA State Medical License
    MA State Medical License Active through 2013
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • ASH Choosing Wisely® Campaign: 2018 ASH Choosing Wisely Champions 
    60th American Society of Hematology Annual Meeting - 12/3/2018

Press Mentions

  • From the Starting Line | Creating a Multidisciplinary Amyloidosis Program: A Practical Guide
    From the Starting Line | Creating a Multidisciplinary Amyloidosis Program: A Practical GuideMarch 1st, 2025
  • Optimal Antibiotics Timing ‘Likely Differs’ Among Inpatients with Cancer, Neutropenic Fever
    Optimal Antibiotics Timing ‘Likely Differs’ Among Inpatients with Cancer, Neutropenic FeverMarch 9th, 2023
  • Delaying Antibiotics for Neutropenic Fever May Not Affect Survival of Cancer Patients
    Delaying Antibiotics for Neutropenic Fever May Not Affect Survival of Cancer PatientsJanuary 1st, 2023
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: